Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M354Revenue $M0.3Net Margin (%)-34,619.9Altman Z-Score5.1
Enterprise Value $M277EPS $-1.5Operating Margin %-35,233.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.8Pre-tax Margin (%)-34,619.1Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %-18.3Quick Ratio6.7Cash flow > EarningsY
Price/Sales1,1865-y EBITDA Growth Rate %6.0Current Ratio6.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-62.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-70.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M59.6ROIC % (ttm)-450.7Gross Margin Increase y-yN

Gurus Latest Trades with ARWR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARWRGeorge Soros 2014-06-30 Sold Out -0.01%$9.79 - $18.28
($13.09)
$ 5.79-56%Sold Out0
ARWRGeorge Soros 2014-03-31 Buy 0.01%$9.92 - $26.57
($17.36)
$ 5.79-67%New holding44,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARWR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ARWR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Myszkowski Kenneth AllenCFO 2015-12-30Sell23,347$6.13-5.55view
Lewis David L.Chief Scientific Officer 2015-01-05Sell15,000$8.01-27.72view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.32-8.39view
Anzalone Christopher RichardPresident and CEO 2014-10-15Buy16,000$6.32-8.39view
McKenney CharlesDirector 2014-10-01Sell2,500$14.7-60.61view
Lewis David L.Chief Scientific Officer 2014-09-30Sell15,000$15.02-61.45view
GIVEN DOUGLAS BDirector 2014-09-26Sell2,000$15.24-62.01view
GIVEN DOUGLAS BDirector 2014-08-15Sell5,000$13.9-58.35view
Myszkowski Kenneth AllenCFO 2014-08-15Sell40,000$14.02-58.7view
McKenney CharlesDirector 2014-06-09Sell22,000$14.32-59.57view

Quarterly/Annual Reports about ARWR:

News about ARWR:

Articles On GuruFocus.com
Arrowhead Research Making Headway In The RNAi Therapy Platform Mar 09 2015 
Weekly CEO Buys Highlight: NRP, OPK, GAM, KEY, ARWR Oct 20 2014 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 10 2011 
Weekly CFO Buys Highlight: JAZZ, VRTB, ASTM, ARWR, CGX Sep 04 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 13 2010 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 11 2010 
Arrowhead Research Corp. Reports Operating Results (10-K) Dec 22 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Aug 10 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) May 15 2009 
Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 09 2009 

More From Other Websites
Arrowhead Pharmaceuticals to Present at Upcoming May Conferences Apr 29 2016
Arrowhead Pharmaceuticals to Present at Upcoming May Conferences Apr 29 2016
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 Apr 28 2016
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 Apr 28 2016
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 Apr 28 2016
Arrowhead Pharmaceuticals Presents Preclinical Data on Renal Cell Carcinoma Program at AACR 2016 Apr 18 2016
Arrowhead Pharmaceuticals Presents Preclinical Data on Renal Cell Carcinoma Program at AACR 2016 Apr 18 2016
Time For Another Biotech Rally Apr 18 2016
4 Hot Trending Small Cap Stocks That You Haven't Heard About Apr 14 2016
Arrowhead Pharmaceuticals Presents Promising ARC-520 Hepatitis B Data at The International Liver... Apr 14 2016
Arrowhead Pharma (ARWR) Stock Spikes on Promising Hepatitis B Data Apr 13 2016
Why JPMorgan (JPM), Facebook (FB), and Fitbit (FIT) Are Among Today’s Trending Stocks Apr 13 2016
Arrowhead Pharmaceuticals Presents Promising ARC-520 Hepatitis B Data at The International Liver... Apr 13 2016
Trending Now: ARWR Apr 12 2016
ARROWHEAD PHARMACEUTICALS, INC. Financials Apr 12 2016
ARROWHEAD RESEARCH CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Apr 06 2016
Arrowhead Research Changes Name to Arrowhead Pharmaceuticals Apr 06 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)